Adma Biologics (ADMA) Other Gross PP&E Adjustments (2016 - 2025)
Adma Biologics' Other Gross PP&E Adjustments history spans 13 years, with the latest figure at $81.9 million for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 20.4% year-over-year to $81.9 million; the TTM value through Dec 2025 reached $81.9 million, up 20.4%, while the annual FY2025 figure was $81.9 million, 20.4% up from the prior year.
- Other Gross PP&E Adjustments reached $81.9 million in Q4 2025 per ADMA's latest filing, up from -$19.9 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $81.9 million in Q4 2025 to a low of -$19.9 million in Q3 2025.
- Average Other Gross PP&E Adjustments over 5 years is $60.3 million, with a median of $64.7 million recorded in 2023.
- Peak YoY movement for Other Gross PP&E Adjustments: increased 25.85% in 2022, then crashed 129.57% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $52.2 million in 2021, then rose by 22.76% to $64.1 million in 2022, then rose by 1.4% to $65.0 million in 2023, then rose by 4.74% to $68.1 million in 2024, then rose by 20.4% to $81.9 million in 2025.
- Per Business Quant, the three most recent readings for ADMA's Other Gross PP&E Adjustments are $81.9 million (Q4 2025), -$19.9 million (Q3 2025), and $74.7 million (Q2 2025).